A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

Part of paid clinical trials in Denver, Colorado.

Sponsor
Verismo Therapeutics
Study ID
NCT06701201
Status
Enrolling By Invitation

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SynKIR-110 — DRUG
    Autologous T cells Transduced with Mesothelin KIR-CAR
  • SynKIR-310 — DRUG
    Autologous T Cells transduced with CD19 KIR-CAR

Study Details

The primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.

Key Dates

First listed
Nov 22, 2024
Start date
Jan 27, 2025
Status verified
Jan 2026
Primary completion
Feb 28, 2042
Completion
Feb 28, 2042

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: SynKIR-110
    Participants who previously received SynKIR-110 in an interventional trial
  • Arm: SynKIR-310
    Participants who previously received SynKIR-310 in an interventional trial

Primary Outcome Measure

To monitor the long-term safety of participants that have been infused with a SynKIR CAR T cell product [ Time Frame: Up to 15 years from SynKIR CAR T cell product administration ]

Locations (6)

FacilityCityStateZIPSite coordinators
Colorado Blood Cancer Institute, part of Sarah Cannon Research InstituteDenverColorado80218-
Winship Cancer Institute of Emory UniversityAtlantaGeorgia30322-
University of Kansas Cancer CenterWestwoodKansas66205-
University of Pennsylvania Abramson Cancer CenterPhiladelphiaPennsylvania19104-
MD Anderson Cancer CenterHoustonTexas77030-
University of Wisconsin Carbone Cancer CenterMadisonWisconsin53792-

Find similar trials in Denver, CO

By research site
Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute· Denver, COWinship Cancer Institute of Emory University· Atlanta, GAUniversity of Kansas Cancer Center· Westwood, KSUniversity of Pennsylvania Abramson Cancer Center· Philadelphia, PAMD Anderson Cancer Center· Houston, TXUniversity of Wisconsin Carbone Cancer Center· Madison, WI

Related Studies